{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:48:37Z","timestamp":1779907717431,"version":"3.53.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016305","name":"First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.117919","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T01:54:19Z","timestamp":1592790859000},"page":"117919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"257","author":[{"given":"Renying","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117919_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11886-019-1240-7","article-title":"Pulmonary hypertension with valvular heart disease: when to treat the valve disease and when to treat the pulmonary hypertension","volume":"21","author":"Martinez","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.lfs.2020.117919_bb0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccm.2013.08.010","article-title":"Epidemiology of pulmonary arterial hypertension","volume":"34","author":"Taichman","year":"2013","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.lfs.2020.117919_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.115.301146","article-title":"Pulmonary arterial hypertension: the clinical syndrome","volume":"115","author":"Lai","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117919_bb0020","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2020.117919_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/humu.22904","article-title":"Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects","volume":"36","author":"Machado","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.lfs.2020.117919_bb0030","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2020.117919_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"Lau","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.117919_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jjcc.2014.06.009","article-title":"Treatment of idiopathic\/hereditary pulmonary arterial hypertension","volume":"64","author":"Matsubara","year":"2014","journal-title":"J. Cardiol."},{"key":"10.1016\/j.lfs.2020.117919_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-319-22671-2_12","article-title":"microRNA and pulmonary hypertension","volume":"888","author":"Boucherat","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2020.117919_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","article-title":"Targeting vascular remodeling to treat pulmonary arterial hypertension","volume":"23","author":"Thompson","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2020.117919_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jash.2014.12.011","article-title":"MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment","volume":"9","author":"Bienertova-Vasku","year":"2015","journal-title":"Journal of the American Society of Hypertension: JASH"},{"key":"10.1016\/j.lfs.2020.117919_bb0060","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1172\/JCI83361","article-title":"MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension","volume":"126","author":"Rothman","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.117919_bb0065","doi-asserted-by":"crossref","first-page":"C363","DOI":"10.1152\/ajpcell.00149.2015","article-title":"miR-223 reverses experimental pulmonary arterial hypertension","volume":"309","author":"Meloche","year":"2015","journal-title":"American Journal of Physiology Cell Physiology"},{"key":"10.1016\/j.lfs.2020.117919_bb0070","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2016.03.140","article-title":"MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3","volume":"473","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117919_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/rcmb.2014-0166TR","article-title":"MicroRNAs in pulmonary arterial hypertension","volume":"52","author":"Zhou","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.117919_bb0080","first-page":"1874","article-title":"Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC","volume":"10","author":"Zhou","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2020.117919_bb0085","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1002\/cam4.1527","article-title":"Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1\u03b1","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.lfs.2020.117919_bb0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharmthera.2013.10.002","article-title":"Targeted therapies in pulmonary arterial hypertension","volume":"141","author":"Montani","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.117919_bb0095","doi-asserted-by":"crossref","first-page":"e64396","DOI":"10.1371\/journal.pone.0064396","article-title":"Circulating miRNAs as potential marker for pulmonary hypertension","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117919_bb0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1164\/rccm.201205-0839OC","article-title":"Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension","volume":"187","author":"Rhodes","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.117919_bb0105","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCRESAHA.115.306806","article-title":"MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension","volume":"117","author":"Deng","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117919_bb0110","first-page":"H839","article-title":"Oxygen regulation of arterial smooth muscle cell proliferation and survival","volume":"294","author":"Ray","year":"2008","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.lfs.2020.117919_bb0115","doi-asserted-by":"crossref","first-page":"e2764","DOI":"10.1038\/cddis.2017.145","article-title":"MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.117919_bb0120","first-page":"446","article-title":"Mechanism of long non-coding RNA MALAT1 in lipopolysaccharide-induced acute kidney injury is mediated by the miR-146a\/NF-kappaB signaling pathway","volume":"41","author":"Ding","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.117919_bb0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","article-title":"SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with snail and HDAC1\/2","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2020.117919_bb0130","series-title":"Long Non-coding RNA FENDRR Reduces Prostate Cancer Malignancy by Competitively Binding miR-18a-5p with RUNX1. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals","first-page":"435","volume":"23","author":"Zhang","year":"2018"},{"key":"10.1016\/j.lfs.2020.117919_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2017.07.101","article-title":"MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway","volume":"491","author":"Geng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117919_bb0140","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ymthe.2016.12.017","article-title":"miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-beta receptor II","volume":"25","author":"Zhang","year":"2017","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.lfs.2020.117919_bb0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4070\/kcj.2014.44.4.255","article-title":"miR-18a-5p microRNA increases vascular smooth muscle cell differentiation by downregulating syndecan4","volume":"44","author":"Kee","year":"2014","journal-title":"Korean Circulation Journal"},{"key":"10.1016\/j.lfs.2020.117919_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051514","article-title":"Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention","volume":"7","author":"Qiao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117919_bb0155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/dvg.22904","article-title":"Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus","volume":"53","author":"Baeten","year":"2015","journal-title":"Genesis (New York, NY: 2000)"},{"key":"10.1016\/j.lfs.2020.117919_bb0160","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1074\/jbc.M115.655548","article-title":"Differential regulation of NOTCH2 and NOTCH3 contribute to their unique functions in vascular smooth muscle cells","volume":"290","author":"Baeten","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.117919_bb0165","doi-asserted-by":"crossref","first-page":"1015.29","DOI":"10.1096\/fasebj.31.1_supplement.1015.29","article-title":"MicroRNA-214\u2013mediated suppression of endothelial-Notch2 signaling potentiates vascular endothelial cell migration and proliferation in pulmonary arterial hypertension","volume":"31","author":"Sahoo","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2020.117919_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/hyp.72.suppl_1.P142","article-title":"Abstract P142: aberrant Notch2 signaling in the vascular endothelium leads to increased proliferation and migration operant in pulmonary arterial hypertension","volume":"72","author":"Sahoo","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2020.117919_bb0175","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr3693","article-title":"MicroRNA-18a inhibits hypoxia-inducible factor 1\u03b1 activity and lung metastasis in basal breast cancers","volume":"16","author":"Krutilina","year":"2014","journal-title":"Breast Cancer Research: BCR"},{"key":"10.1016\/j.lfs.2020.117919_bb0180","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3892\/etm.2015.2630","article-title":"MicroRNA-18a regulates invasive meningiomas via hypoxia-inducible factor-1\u03b1","volume":"10","author":"Li","year":"2015","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.lfs.2020.117919_bb0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3892\/etm.2015.2546","article-title":"microRNA-18a regulates gastric carcinoma cell apoptosis and invasion by suppressing hypoxia-inducible factor-1\u03b1 expression","volume":"10","author":"Wu","year":"2015","journal-title":"Experimental and Therapeutic Medicine"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052030669X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052030669X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:14:30Z","timestamp":1765228470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052030669X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"alternative-id":["S002432052030669X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117919","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117919"}}